Related Experiment Video
Updated: Jun 5, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Clot waveform analysis in hemophilia carriers
Eya Drissi1, Fatma Ben Lakhal, Ons Ghali
1Biological Hematology Department, Aziza Othmana Hospital, Tunis, Tunisia.
Activated partial thromboplastin time clot waveform analysis (APTT-CWA) shows promise for identifying hemophilia carriers and assessing bleeding tendencies. This method effectively differentiates carriers from controls and correlates with bleeding symptoms.
Area of Science:
- Hematology
- Coagulation Science
Background:
- Activated partial thromboplastin time clot waveform analysis (APTT-CWA) is gaining attention for its ability to reflect clot formation dynamics.
- Previous research primarily focused on APTT-CWA in hemophilia and disseminated intravascular coagulation.
Purpose of the Study:
- To investigate the utility of APTT-CWA in identifying hemophilia carriers.
- To assess the correlation between APTT-CWA parameters and bleeding tendencies in carriers.
Main Methods:
- Cross-sectional study comparing 32 hemophilia carriers with 30 healthy women.
- Evaluated bleeding using the ISTH-BAT, alongside APTT, APTT-CWA, and factor VIII/IX:C levels.
- Utilized ROC analysis to determine diagnostic accuracy of APTT-CWA parameters.
Main Results:
- APTT was prolonged in 14 carriers. APTT-CWA parameters (Tmax 1, Tmax 2, Max 1, Max 2) differed significantly between carriers and controls.
- APTT-CWA cut-offs demonstrated good sensitivity and specificity for carrier detection.
- Significant differences in APTT-CWA parameters were observed between bleeding and non-bleeding carriers. FVIII:C correlated positively with Max 2 and negatively with Tmax 1, Tmax 2, and Min 2.
Conclusions:
- APTT-CWA appears to be a valuable tool for evaluating bleeding risk and detecting coagulation factor deficiencies.
- Further research is recommended to fully establish APTT-CWA's role in identifying hemophilia carriers.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
06:16Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
Related Concept Videos
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...